XORTX Therapeutics
XRTX
6 hedge funds and large institutions have $1.24M invested in XORTX Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
4,041% more capital invested
Capital invested by funds: $30K → $1.24M (+$1.21M)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
50% more funds holding
Funds holding: 4 → 6 (+2)
0.03% more ownership
Funds ownership: 0% → 0.03% (+0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.31M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$15.6K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$355 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$355 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $1.21M | +$1.31M | +3,686 | New |
|
2
CIBC World Market
Toronto,
Ontario, Canada
| $16K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $14.7K | +$15.6K | +44 | New |
|
4
Osaic Holdings
Scottsdale,
Arizona
| $3K | – | – | – |
|
|
CA
5
Clearstead Advisors
Cleveland,
Ohio
| $2.02K | – | – | – |
|
6
UBS Group
Zurich,
Switzerland
| $53 | – | – | – |
|
|
7
Bank of America
Charlotte,
North Carolina
| $2 | -$355 | -1 | Closed |
|
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$355 | +1 | New |
|
XRTX Hedge Fund Activity: Q4 2022 in Review
6 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in XORTX Therapeutics (XRTX) for Q4 2022, worth a combined $1.24M — up 4,041% from $30K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new XRTX positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.31M. The largest seller was Bank of America, exiting entirely with an estimated $355 sold.
- 6 institutional investors held XORTX Therapeutics (XRTX) as of Q4 2022, up from 4 in Q3 2022.
- Funds reported $1.24M of XORTX Therapeutics stock for Q4 2022, up 4,041% quarter-over-quarter.
- 3 funds opened new XORTX Therapeutics positions in Q4 2022 and 1 closed out, a net change of +2 holders.
- The largest XORTX Therapeutics buyer in Q4 2022 was Armistice Capital, an estimated $1.31M added.
- The largest XORTX Therapeutics seller in Q4 2022 was Bank of America, an estimated $355 sold.
Based on aggregated 13F filings for Q4 2022.